The Small Molecule Drug Discovery by The Business Research Company provides market overview across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Small Molecule Drug Discovery Market:
https://www.thebusinessresearchcompany.com/report/small-molecule-drug-discovery-global-market-report

According to The Business Research Company’s Small Molecule Drug Discovery, The small molecule drug discovery market size has grown strongly in recent years. It will grow from $57.41 billion in 2023 to $63.15 billion in 2024 at a compound annual growth rate (CAGR) of 10.0%.  The growth in the historic period can be attributed to drug repurposing initiatives, automation in drug discovery, increased investment in r&d, regulatory support for drug development, advancements in high-throughput screening.

The small molecule drug discovery market size is expected to see rapid growth in the next few years. It will grow to $95.63 billion in 2028 at a compound annual growth rate (CAGR) of 10.9%.  The growth in the forecast period can be attributed to emergence of novel therapeutic targets, patient-centric drug discovery, drug-device combination products, real-world evidence utilization, pharmacogenomics integration, global health challenges. Major trends in the forecast period include fragment-based drug discovery, integration of artificial intelligence in drug discovery, rna-targeted therapeutics, collaborations and partnerships, innovations in drug delivery, adoption of organoids and 3d cell culture models.

The rising incidence of chronic diseases is expected to boost the growth of the small molecule drug discovery market going forward. Chronic diseases refer to conditions that last for a year or longer, hinder everyday activities, demand continuous medical care, or both. Small-molecule medications can be used to treat chronic conditions like HIV, cancer, infections, heart disease, and renal disease, and these medications are generally more economical for patients with chronic conditions. Hence, the rising incidence of chronic diseases is expected to boost the small molecule drug discovery market. For instance, according to a report published by the National Institutes of Health (NIH), a US-based biomedical research agency, in 2023, in the United States, the number of people aged 50 and older with at least one chronic illness is predicted to rise by 99.5%, from 71.522 million in 2020 to 142.66 million in 2050. Additionally, the number of people with multimorbidity would rise by 91.16% from 7.8304 million in 2020 to 14.968 million in 2050. Therefore, the rising incidence of chronic diseases is driving the growth of the small molecule drug discovery market.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=9834&type=smp

The small molecule drug discovery market covered in this report is segmented –
1) By Drug Type: Small Molecule Drugs, Biologic Drugs
2) By Technology: High Throughput Screening, Pharmacogenomics, Combinatorial Chemistry, Nanotechnology, Others
3) By Therapeutic Area: Oncology, Central Nervous System, Cardiovascular, Respiratory, Metabolic Disorders, Gastrointestinal, Others
4) By Process/Phase: Target ID Or Validation, Hit Generation And Selection, Lead Identification, Lead Optimization
5) By End-User: Pharmaceutical Companies, Contract Research Organizations, Others

Top Major Players:

Pfizer Inc.
GlaxoSmithKline PLC
AstraZeneca
Boehringer Ingelheim International GmbH
Bristol-Myers Squibb Company

North America was the largest region in the small molecule drug discovery market in 2023.

Technological innovations are the key trend gaining popularity in the small molecule drug discovery market. Major companies operating in the small molecule drug discovery market are focusing on developing new products. For instance, in January 2023, Dotmatics, a US-based provider of digital science platform, launched Small Molecule Drug Discovery Solution. It is uniquely designed with integrated scientific R&D platform that has pre-configured workflows and expanded data management capabilities. It reduces the operational inefficiencies, and speeds the process of taking data from insights to decisions.

The small molecule drug discovery market report table of contents includes:
1. Executive Summary
2. Small Molecule Drug Discovery Market Characteristics
3. Global Small Molecule Drug Discovery Market Trends And Strategies
4. Small Molecule Drug Discovery Market - Macro Economic Scenario
5. Global Small Molecule Drug Discovery Market Size and Growth
…….
26. Global Small Molecule Drug Discovery Market Competitive Benchmarking
27. Global Small Molecule Drug Discovery Market Competitive Dashboard
28. Key Mergers and Acquisitions Small Molecule Drug Discovery Market
29. Small Molecule Drug Discovery Market Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany 

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/ 

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model